ITP and Leukopenia in Toddlers: Treatment Insights - Pediatrics

Share to:

Child with thrombocytopenia due to immune thrombocytopenic purpura (ITP) and leukopenia?


A two-year-old child has been diagnosed with ITP and has been undergoing treatment with romiplostim for over a month.
I would like to ask if it is common for platelet counts to fluctuate during treatment with romiplostim.
The most recent follow-up visit showed that the white blood cell count was slightly below the standard range.
Is it possible that the low white blood cell count is still a result of the romiplostim treatment after more than a month?

Elsa, 0~9 year old female. Ask Date: 2022/09/05

Dr. Xiao Kaiwen reply Pediatrics


The second-line targeted therapy for ITP, Eltrombopag, is effective in approximately 60% of patients initially, meaning that 40% of patients may not respond to treatment, which could result in fluctuating platelet counts.
The hematological side effects of Eltrombopag include anemia (8-35%), lymphocytopenia (48%), and leukopenia (8-25%), indicating that leukopenia is a possible occurrence.

Reply Date: 2022/09/05

More Info


Immune Thrombocytopenic Purpura (ITP) is a condition characterized by a low platelet count, which can lead to easy bruising and bleeding. In toddlers, ITP is often idiopathic, meaning the exact cause is unknown, but it can sometimes follow a viral infection. Treatment options for ITP can vary, and one of the medications used is called "methylprednisolone" (often referred to as "methylpred" or "Medrol"). This corticosteroid helps to increase platelet counts by dampening the immune response that is destroying the platelets.

Regarding your question about fluctuating platelet counts during treatment with methylprednisolone, it is indeed common for platelet levels to vary. Corticosteroids can lead to an increase in platelet production, but the response can be inconsistent. Some children may experience a significant rise in platelet counts, while others may see only a modest increase or fluctuations. This variability can be influenced by several factors, including the child's overall health, any concurrent infections, and the body's response to the medication.

As for the leukopenia (low white blood cell count) you mentioned, it is important to note that while corticosteroids can sometimes lead to changes in white blood cell counts, they typically cause an increase in white blood cells due to the release of cells from the bone marrow and a decrease in the migration of white blood cells to tissues. However, in some cases, especially with prolonged use or higher doses, they can lead to a decrease in certain types of white blood cells.
In your child's case, if the white blood cell count is slightly below the standard range after a month of treatment, it is essential to monitor this closely. Mild leukopenia can occur and may not necessarily be a cause for concern, especially if the child is otherwise healthy and not showing signs of infection or other complications. However, it is crucial to discuss these findings with your pediatrician or a pediatric hematologist, who can provide tailored advice based on your child's specific situation.

In summary, fluctuations in platelet counts during treatment for ITP with methylprednisolone are common and can be expected. Mild leukopenia can also occur, but it is essential to keep your healthcare provider informed about any changes in your child's blood counts. Regular follow-ups and blood tests will help ensure that any potential issues are addressed promptly. Always consult with your healthcare provider for the most accurate information and guidance tailored to your child's health needs.

Similar Q&A

Understanding the Mechanism of Danazol in Treating ITP in Children

Hello, my child is currently two years old. A few months ago, we discovered that their platelet count was as low as 2000. They were hospitalized and treated with intravenous steroids and IVIG, but there was no improvement. We are currently trying Danazol (0.5 tablets twice a day)...


Dr. Liao Lingmei reply Pharmacology
Dear: If children with ITP do not achieve satisfactory results with steroids or IVIG, some treatment recommendations (highlighted in red in Attachment 1) or literature (summary of literature in Attachment 2 - full text unavailable) indicate that Danazol may be used. The detailed ...

[Read More] Understanding the Mechanism of Danazol in Treating ITP in Children


Understanding ITP and Lymphadenopathy in Pediatric Patients

Hello Doctor, thank you for your prompt response to the previous question <a href="https://adoctor.tw/article/199203">#199203</a>. I would like to provide some additional information. The child in the family has had elevated infection markers and lymphadenop...


Dr. Xiao Kaiwen reply Pediatrics
An elevated CRP (C-reactive protein) level indicates a wide range of possibilities. While the likelihood of infection is highest in children, there are still other potential causes. It is difficult to specify which additional tests should be arranged at this point; however, it is...

[Read More] Understanding ITP and Lymphadenopathy in Pediatric Patients


Using Rebinin in Pediatric ITP: Is Bone Marrow Monitoring Required?

I would like to ask if the standard protocol for administering low-dose Rituximab to children for the treatment of ITP includes the requirement for regular bone marrow aspiration for monitoring.


Dr. Xiao Kaiwen reply Pediatrics
The use of intravenous immunoglobulin (IVIG) in the treatment of Immune Thrombocytopenic Purpura (ITP) is considered a later-line therapy, indicating a more complex condition. The chemotherapy protocols in pediatric hematology-oncology are very detailed, cautious, and highly prof...

[Read More] Using Rebinin in Pediatric ITP: Is Bone Marrow Monitoring Required?


Sirolimus for Treating Pediatric ITP: Case Studies and Insights

Is there any case of sirolimus being used in the treatment of thrombocytopenic purpura in infants?


Dr. Xiao Kaiwen reply Pediatrics
Sirolimus is an immunosuppressive medication that can be used for treating pediatric immune thrombocytopenia (ITP) caused by autoimmune antibodies destroying platelets. However, it is generally considered a second-line therapy, typically used after first-line treatments have prov...

[Read More] Sirolimus for Treating Pediatric ITP: Case Studies and Insights


Related FAQ

Thalassemia

(Pediatrics)

Platelets

(Pediatrics)

Purpura

(Pediatrics)

Candidiasis

(Pediatrics)

Lymph

(Pediatrics)

Pediatric Cold

(Pediatrics)

Kidney

(Pediatrics)

Stroke

(Pediatrics)

Well-Child Clinic

(Pediatrics)

Pediatric Vomiting

(Pediatrics)